65,437 trials
Combat Disorders · Stress Disorders, Post-Traumatic
Primary: Change in Clinician-Administered PTSD Scale for DSM-IV Total Score. — 72.15; 68.78; 67.90; 51.52 units on a scale — p=<0.05
Prostate Cancer
Primary: Percent Probability of Participants With 6-month Progression-free Survival (PFS) — 43.9 percent probability
Tourette Syndrome
Primary: Yale Global Tic Severity Scale — 23.2; 21.7 units on a scale (0 - 50)
Pulmonary Disease, Chronic Obstructive
Primary: FEV1 Area Under Curve 0-12 h (AUC 0-12h) Response After 3 Weeks of Treatment — 0.155; 0.209; 0.189; 0.204 Liter — p=0.3011
Anxiety Disorders in Youth With Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified
Primary: Pediatric Anxiety Rating Scale. — 11.62; 14.04 units on a scale — p=.04
Sinusitis, Acute
Primary: Number of Participants With a Clinical Outcome of "Cure" at Test of Cure (TOC: Day 15) — 23; 3; 0 Participants
Follow-up After Uterine Evacuation
Primary: Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete…
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 16 — 0.28; -0.61; -1.27; -0.82 Percentage of HbA1c in the blood — p=<0.0001
Epilepsy
Primary: Number of Spikes and Sharp Waves, Relative Change From Baseline to Treatment Day (%). — -7.4; -26.1 percentage of baseline
HIV Infection
Primary: Endothelial Function (Brachial Artery Reactivity) — 3.98; 3.37 percent dilation — p=0.10
Varicocele
Primary: Recurrent Varicocele — 2; 16 participants
Tick Bites · Tick-borne Illness
Primary: Work Related Tick Bites — 265; 780 tick bites — p=0.004
Menopause · Vasomotor Symptoms
Primary: Change From Baseline in Average Daily Frequency of Vasomotor Symptoms (Frequency Score A) at Week 4 — -3.9; -5.6; -6.0; -6.0 Number of events — p=<0.01
Social Intelligence
Primary: Affective Ratings in Affective Learning Task — -0.096; -0.12 units on a scale
Central Retinal Vein Occlusion
Primary: Change From Baseline in Visual Acuity Using Early Treatment Diabetic Retinopathy Study (ETDRS) Charts — 12.5; 14; 13.5 letters read correctly